Vanda Pharmaceuticals starts Phase III Covid-19 trial of tradipitant

SARS-CoV-2, the novel coronavirus that causes Covid-19, leads to the lower respiratory tract inflammation. Credit: Daniel Roberts from Pixabay.



  • tradipitant